Company: EDSA
Filing Date: 2025-04-04
Form Type: DEFA14A
Source: 0001171843-25-002029
Chunk: 0

Company: Edesa Biotech, Inc.
Filing Date: 2025-04-04
Form: DEFA14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act
of 1934</div>

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

| ☐ | Preliminary Proxy Statement                                                     |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement                                                      |
| ☒ | Definitive Additional Materials                                                 |
| ☐ | Soliciting Material under §240.14a-12                                           |

| Edesa Biotech, Inc.                              |
| (Name of Registrant as Specified In Its Charter) |

| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |

| Payment of Filing Fee (Check the appropriate box): |

| ☒ | No fee required.                                                                                     |
| ☐ | Fee paid previously with preliminary materials.                                                      |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |